Petros Pharmaceuticals, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -25.3% | -25.3% | -13.3% |
| FY2022 | -120.0% | -120.0% | -61.8% |
| FY2023 | -67.6% | -67.6% | -24.2% |
| FY2024 | 191.7% | 191.7% | -134.6% |
| FY2025 | 66.7% | 66.7% | 37.1% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -25.3% | -25.3% | -13.3% |
| FY2022 | -120.0% | -120.0% | -61.8% |
| FY2023 | -67.6% | -67.6% | -24.2% |
| FY2024 | 191.7% | 191.7% | -134.6% |
| FY2025 | 66.7% | 66.7% | 37.1% |